ENSURING THE FDA FULLY EXAMINES CLINICAL TRIAL IMPACT AND VITALNESS BEFORE ENDORSEMENT (EFFECTIVE) ACT

Bills and resolutions

Enact (see S. 4340), S2752 [26MY] (see H.R. 8586), H7405 [28JY]